CG ONCOLOGY INC (CGON) Stock Analyst Ratings
USA - NASDAQ:CGON - US1569441009 - Common Stock
43.67 USD
+1.69 (+4.03%)
43.67 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 82% to CGON. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 65.99. This target is 51.12% above the current price.
CGON was analyzed by 18 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CGON.
In the previous month the buy percentage consensus was at a similar level.
CGON was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-08 | Guggenheim | Initiate | Buy |
| 2025-09-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Jones Trading | Initiate | Buy |
| 2025-09-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-07-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-17 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-02 | JP Morgan | Initiate | Overweight |
| 2025-04-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-28 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-16 | ScotiaBank | Initiate | Sector Perform |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | TD Cowen | Initiate | Buy |
| 2024-12-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-12-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | UBS | Initiate | Buy |
| 2024-10-08 | B of A Securities | Maintains | Buy -> Buy |
| 2024-09-23 | RBC Capital | Initiate | Outperform |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
CG ONCOLOGY INC / CGON FAQ
What do analysts expect the price target to be for CG ONCOLOGY INC (CGON)?
18 analysts have analysed CGON and the average price target is 65.99 USD. This implies a price increase of 51.12% is expected in the next year compared to the current price of 43.67.
What is the consensus rating for CGON stock?
The consensus rating for CG ONCOLOGY INC (CGON) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for CG ONCOLOGY INC stock?
The number of analysts covering CG ONCOLOGY INC (CGON) is 18.